Standout Papers

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease pro... 2006 2026 2012 2019 2.3k
  1. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis (2006)
    Heidi Phillips, Samir Kharbanda et al. Cancer Cell
  2. The transcriptional network for mesenchymal transformation of brain tumours (2009)
    Maria Stella Carro, Wei Keat Lim et al. Nature
  3. cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV” (2018)
    Daniel J. Brat, Kenneth Aldape et al. Acta Neuropathologica
  4. Glioma Subclassifications and Their Clinical Significance (2017)
    Matthew Smith-Cohn, Adam L. Cohen et al. Neurotherapeutics
  5. FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis (2011)
    Nu Zhang, Ping Wei et al. Cancer Cell
  6. IDH1 and IDH2 Mutations in Gliomas (2013)
    Adam L. Cohen, Sheri L. Holmen et al. Current Neurology and Neuroscience Reports
  7. Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study (2015)
    Nicholas Butowski, Howard Colman et al. Neuro-Oncology
  8. cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas (2020)
    Daniel J. Brat, Kenneth Aldape et al. Acta Neuropathologica

Immediate Impact

5 by Nobel laureates 18 from Science/Nature 134 standout
Sub-graph 1 of 16

Citing Papers

Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression
2024 Standout
Glioblastoma and Other Primary Brain Malignancies in Adults
2023 Standout
11 intermediate papers

Works of Howard Colman being referenced

Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas:Guideline from the College of American Pathologists in Collaboration with the American Association of Neuropathologists, Association for Molecular Pathology, and Society for Neuro-Oncology
2022
Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients
2014
and 9 more

Author Peers

Author Last Decade Papers Cites
Howard Colman 5868 2752 3671 5534 149 11.3k
Jason T. Huse 4665 2810 3569 6040 129 12.0k
Peter Hau 6746 2717 3162 4991 187 11.6k
Hai Yan 5394 2198 4557 7032 89 12.3k
D. Williams Parsons 4557 1901 3246 5195 91 9.9k
Linda M. Liau 5683 3199 3883 5942 218 13.4k
Rolf Bjerkvig 3722 3340 3274 6199 232 12.5k
Ingo K. Mellinghoff 3203 2077 3479 6181 154 11.2k
Christel Herold‐Mende 5453 4206 3577 6169 308 14.1k
Annick Desjardins 6152 2593 2115 3169 247 9.7k
W.K. Alfred Yung 6307 3782 3154 7966 175 14.7k

All Works

Loading papers...

Rankless by CCL
2026